The Impact of MFN Pricing on the U.S. Biosimila...

By Rene Pretorius

May 23, 2025

Could a cost-cutting policy designed to rein in drug prices backfire on biosimilar competition? The Most Favored Nation
Hepatitis Vaccine Uptake: Trends, Challenges, and the Role of Pharmacists
Biosimilars Price Competition: Impact on U.S. Pharmaceutical Pricing and Mark...
MFN Drug Pricing Targets: Lowering U.S. Drug Costs Through International Alig...
Drug Pricing Analysis: ICER’s Launch Price and Access Report Aims to En...
Trends in Anticancer Drug Pricing: Analyzing Medicare Launch Prices and Impac...
Publication Delays Impact Careers of Early-Career Researchers
A System Dynamics Approach to Lowering Drug Prices by 30–80% in the US
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control
FDA AI Drug Approval
HCV Treatment Advancements: Atea Pharmaceuticals KOL Panel
Wegovy CVS Deal: Hybrid Market Access Strategy Insights